Carboplatin Plus Topotecan in Treating Patients With Relapsed Acute Myelogenous Leukemia

NCT00003255 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Leukemia

Interventions

DRUG: carboplatin
DRUG: topotecan hydrochloride

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]